Loading...
Loading...
By Hector Salinas - Fri, 11/07/2025 - 06:00
To capitalize on global R&D momentum, Mexico must ensure regulatory harmonization becomes an operationalized reality, writes Héctor Salinas.
Featured content
Partnership Content
https://mexicobusiness.news/tag/biologics
More Health
By Hector Salinas - Wed, 10/08/2025 - 07:00
As the global pharma market shifts due to the expansion of generics, Mexico is emerging as a leader in novel drug registration, writes Héctor Salinas.
By José Escobedo - Mon, 08/25/2025 - 15:45
This investment is part of a broader MX$3.5 billion allocation in Mexico over the next five years.
By Sofía Garduño - Tue, 07/22/2025 - 08:17
J&J submits NDA for icotrokinra, an oral IL-23 blocker for plaque psoriasis, based on four Phase 3 trials showing strong efficacy and safety.
By MBN Staff - Fri, 07/18/2025 - 12:53
Waters and BD will merge biosciences and diagnostics units in a US$17.5 billion deal, creating a life sciences and diagnostics leader.
By Juan Luis Serrano Leets - Mon, 03/10/2025 - 06:30
Mexico's patent and biosimilar regulations lack transparency and efficiency. Reform is needed, writes Juan Luis Serrano Leets.
By Sandra Sánchez-Oldenhage - Thu, 02/20/2025 - 08:30
Mexico can become a top pharma hub by boosting API production, nearshoring, and aligning trade policies, writes Sandra Sánchez-Oldenhage.
By MBN Staff - Wed, 02/12/2025 - 17:53
New data from Eli Lilly's VIVID-2 study shows that Omvoh sustains clinical and endoscopic benefits in Crohn’s disease over two years.
By MBN Staff - Fri, 01/10/2025 - 09:30
UPS enhances healthcare logistics through key acquisitions, expanding its capabilities to transport temperature-sensitive products and biologics.
By Juan Luis Serrano Leets - Thu, 12/12/2024 - 16:00
With a newly designated head commissioner, Juan Luis Serrano looks at the key challenges COFEPRIS will likely face in 2025.
